 Phage therapy has been found to be effective in treating non-alcoholic fatty liver disease, NAFLD, caused by high levels of alcohol-producing Klebsiella pneumoniae, high-out KPN. This study showed that high-out KPN, specific phage were able to reduce steto-hypatis symptoms without causing significant damage to the liver or other organs. Additionally, phage therapy reduced inflammation and improved lipid and carbohydrate metabolism. This article was authored by Lin Gan, Yang Ling Feng, Bindu, and others.